BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16480497)

  • 1. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole.
    Park DW; Sohn JW; Cheong HJ; Kim WJ; Kim MJ; Kim JH; Shin C
    BMC Infect Dis; 2006 Feb; 6():26. PubMed ID: 16480497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy of caspofungin alone and in combination with amphotericin B deoxycholate for coccidioidomycosis in a mouse model.
    González GM; González G; Najvar LK; Graybill JR
    J Antimicrob Chemother; 2007 Dec; 60(6):1341-6. PubMed ID: 17934204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections.
    Nivoix Y; Zamfir A; Lutun P; Kara F; Remy V; Lioure B; Rigolot JC; Entz-Werlé N; Letscher-Bru V; Waller J; Levêque D; Koffel JC; Beretz L; Herbrecht R
    J Infect; 2006 Jan; 52(1):67-74. PubMed ID: 16368463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coccidioidomycosis in infants: A retrospective case series.
    Lee JM; Graciano AL; Dabrowski L; Kuzmic B; Tablizo MA
    Pediatr Pulmonol; 2016 Aug; 51(8):858-62. PubMed ID: 26829719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on treatment of coccidioidomycosis.
    Mirels LF; Stevens DA
    West J Med; 1997 Jan; 166(1):58-9. PubMed ID: 9074341
    [No Abstract]   [Full Text] [Related]  

  • 6. Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
    Lye DC; Hughes A; O'Brien D; Athan E
    Eur J Clin Microbiol Infect Dis; 2005 Nov; 24(11):753-5. PubMed ID: 16283214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.
    Levy ER; McCarty JM; Shane AL; Weintrub PS
    Clin Infect Dis; 2013 Jun; 56(11):1573-8. PubMed ID: 23463636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin.
    Aliff TB; Maslak PG; Jurcic JG; Heaney ML; Cathcart KN; Sepkowitz KA; Weiss MA
    Cancer; 2003 Feb; 97(4):1025-32. PubMed ID: 12569602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
    Manfredi R; Sabbatani S
    Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant recipient.
    Antony S
    Clin Infect Dis; 2004 Sep; 39(6):879-80. PubMed ID: 15472833
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
    del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
    Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate.
    Goodman D; Pamer E; Jakubowski A; Morris C; Sepkowitz K
    Clin Infect Dis; 2002 Aug; 35(3):E35-6. PubMed ID: 12115115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis.
    Antony S; Dominguez DC; Sotelo E
    J Natl Med Assoc; 2003 Oct; 95(10):982-5. PubMed ID: 14620712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miliary coccidioidomycosis in the immunocompetent.
    Arsura EL; Kilgore WB
    Chest; 2000 Feb; 117(2):404-9. PubMed ID: 10669682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential therapy with caspofungin and fluconazole for Candida albicans infection.
    Barchiesi F; Spreghini E; Baldassarri I; Marigliano A; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2004 Oct; 48(10):4056-8. PubMed ID: 15388480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin in the treatment of azole-refractory esophageal candidiasis in kidney transplant recipients.
    Veroux M; Macarone M; Fiamingo P; Cappello D; Gagliano M; Di Mare M; Vizcarra D; Spataro M; Giuffrida G; Sorbello M; Severino V; Veroux P
    Transplant Proc; 2006 May; 38(4):1037-9. PubMed ID: 16757256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspofungin therapy of neonates with invasive candidiasis.
    Odio CM; Araya R; Pinto LE; Castro CE; Vasquez S; Alfaro B; Sàenz A; Herrera ML; Walsh TJ
    Pediatr Infect Dis J; 2004 Dec; 23(12):1093-7. PubMed ID: 15626944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of caspofungin in the treatment of obstructive pyonephrosis due to Candida glabrata infection.
    Schelenz S; Ross CN
    BMC Infect Dis; 2006 Aug; 6():126. PubMed ID: 16895593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspofungin versus amphotericin B for invasive candidiasis.
    Brown AL; Greig JR
    N Engl J Med; 2003 Mar; 348(13):1287-8; author reply 1287-8. PubMed ID: 12660396
    [No Abstract]   [Full Text] [Related]  

  • 20. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
    Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
    J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.